The Wistar Institute
Wistar Science Highlights: Advances in Ovarian Cancer Research and the Impact of p53 Genetic Variant on Iron Accumulation in African Americans
The TP53 gene is the most frequently mutated gene in human cancer. In addition to mutations, this gene comes in numerous variations in the human population. Some of these variations alter the function of the p53 protein. A collaborative study fro…
The World Is a Lot Smaller Than You Think
Nikon Small World opening night brought to Wistar a crowd of science and art enthusiasts to marvel at the beautiful images of 2019 and listen to first-place winners talk about the work behind their winning image — made up of more than one thousand…
Novel Combination Strategy to Expand PARP Inhibitors for Ovarian Cancer Treatment
PHILADELPHIA — (Jan. 30, 2020) — Combining EZH2 inhibition and PARP1 inhibition may provide a new therapeutic strategy for ovarian cancers that have functional DNA damage repair and thus would not typically respond to PARP inhibitor treatment alon…
TP53 Genetic Variant Found in Individuals of African Descent is Linked to Iron Overload but May Improve Response to Malaria
PHILADELPHIA — (Jan. 24, 2020) — In a study by The Wistar Institute and collaborators, a rare, African-specific variant of the TP53 gene called P47S causes iron accumulation in macrophages and other cell types and is associated with poorer respons…
Wistar Joins Global Effort to Expedite Coronavirus Vaccine Development
PHILADELPHIA — (Jan. 23, 2020) — The Wistar Institute announces today that they are part of a team to develop a vaccine against the recently emerged strain of coronavirus (2019-nCoV) that has infected hundreds in China and other countries, includi…
Wistar Scientists Discover Link Between a Genetic Driver of Ovarian Cancer and Metabolism, Opening the Way for New Therapeutic Strategies
PHILADELPHIA — (Jan. 11, 2020) — Mutations that inactivate the ARID1A gene in ovarian cancer increase utilization of the glutamine amino acid making cancer cells dependent on glutamine metabolism, according to a study by The Wistar Institute publi…
The Wistar Institute Receives Generous Support From Foundations
PHILADELPHIA — (Dec. 19, 2019) — In the past six months, scientists at The Wistar Institute received funding from private foundations totaling $2,418,000 that will fuel new discoveries in cancer, immunology and infectious diseases. ### The Wistar …
New Therapeutic Strategy for Chemotherapy Resistance in Ovarian Cancer
PHILADELPHIA — (Dec. 19, 2019) — A study from The Wistar Institute demonstrated that NAMPT, an enzyme critical for NAD+ biosynthesis, mediates selection of stem-like chemoresistant cells following cisplatin treatment. Researchers showed that a com…
Microscopic World Comes Alive During Nikon Small World Exhibit
PHILADELPHIA — (Dec. 17, 2019) — See cellular images as distinct as abstract art, minerals appear as future urban landscapes, single-celled organisms of the microscopic netherworld, and much more from the 2019 Nikon Small World competition of phot…
Keerthana Gnanapradeepan is the 2019 Monica H.M. Shander Memorial Fellowship Awardee
Keerthana Gnanapradeepan, a trainee in the Murphy lab, is the recipient of the 2019 Monica H.M. Shander Memorial Fellowship Award. This prestigious award was established in 1981 in memory of former Wistar predoctoral trainee Monica&…